文献速递消化道肿瘤放疗放疗物理与技术

1.5 T MR-linac前瞻性与自适应直肠加量计划对比研究

1.5 T MR-linac planning study to compare two different strategies of rectal boost irradiation.
PubMed 文献 · Clin Transl Radiat Oncol · 2020-12-03

本研究在1.5 T MR-linac上比较局部晚期直肠癌前瞻性加量与自适应加量两种策略的计划差异。5例患者共44套MRI用于模拟两种策略并采用标准与缩小PTV margin。自适应加量PTV体积显著更小,缩小margin时直肠V60Gy和V65Gy显著更低,结论提示自适应加量可能更好保护直肠和肛管。

要点

  • 自适应加量PTV体积显著小于前瞻性加量,标准margin下81.4 cm3 vs 44.4 cm3。
  • 缩小margin时自适应加量直肠V60Gy和V65Gy显著低于前瞻性加量。
  • 分次内GTV运动中位2 mm(范围0-8 mm),需个体化margin与运动管理。

核心结论

  • 数据提示利用肿瘤缩小和缩小margin的自适应加量策略可能更好保护直肠和肛管。
  • 个体化margin评估、运动管理和实时自适应放疗是1.5 T MR-linac用于直肠癌个体化安全剂量递增的吸引人应用。

研究设计与样本

  • 计划研究,比较1.5 T MR-linac上前瞻性加量与自适应加量两种直肠加量策略。
  • 纳入5例局部晚期直肠癌患者,均接受50.4 Gy/28次标准新辅助放化疗。
  • 治疗前和治疗后采集T2加权MRI用于勾画GTV和OAR,共评估44套MRI。
  • 模拟四种加量策略,均为在50.4 Gy基础上追加15 Gy/5次:前瞻性加量(治疗第一周连续5次每日加量)和自适应加量(每周一次加量),各采用标准和缩小PTV margin。
  • 通过治疗前和治疗后MRI勾画评估分次内运动。

主要发现

  • 自适应加量中位PTV体积显著小于前瞻性加量:标准margin下81.4 cm3 vs 44.4 cm3,缩小margin下31.2 cm3 vs 15 cm3(p = 0.031)。
  • 缩小margin时自适应加量较前瞻性加量显著更好保护直肠:V60Gy和V65Gy分别为41.2%和24.8% vs 59%和29.9%(p = 0.031)。
  • 中位GTV分次内运动为2 mm(范围0-8 mm)。

关键数值与推荐

  • 标准新辅助放化疗剂量为50.4 Gy/28次。
  • 两种加量策略均在50.4 Gy基础上追加15 Gy/5次。
  • 自适应加量中位PTV体积:标准margin 44.4 cm3,缩小margin 15 cm3。
  • 前瞻性加量中位PTV体积:标准margin 81.4 cm3,缩小margin 31.2 cm3。
  • 缩小margin时直肠V60Gy和V65Gy:自适应加量41.2%和24.8%,前瞻性加量59%和29.9%(p = 0.031)。

临床怎么用

  • 在1.5 T MR-linac上可考虑利用肿瘤缩小实施自适应加量以缩小PTV并更好保护直肠和肛管。
  • 需结合个体化margin评估和分次内运动管理(中位2 mm,范围0-8 mm)制定加量方案。
  • 实时自适应放疗可作为直肠癌个体化安全剂量递增的进一步测试方向。

局限性

  • 样本量仅5例患者,共44套MRI,结果需更大样本验证。
  • 为计划研究,未报告临床结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare treatment plans of two different rectal boost strategies: up-front versus adaptive boost at the 1.5 T MR-Linac. METHODS: Patients with locally advanced rectal cancer (LARC) underwent standard neoadjuvant radiochemotherapy with 50.4 Gy in 28 fractions. T2-weighted MRI prior and after the treatment session were acquired to contour gross tumor volumes (GTVs) and organs at risk (OARs). The datasets were used to simulate four different boost strategies (all with 15 Gy/5 fractions in addition to 50.4 Gy): up-front boost (5 daily fractions in the first week of treatment) and an adaptive boost (one boost fraction per week). Both strategies were planned using standard and reduced PTV margins. Intra-fraction motion was assessed by pre- and post-treatment MRI-based contours. RESULTS: Five patients were included and a total of 44 MRI sets were evaluated. The median PTV volumes of the adaptive boost were significantly smaller than for the up-front boost (81.4 cm3 vs 44.4 cm3 for PTV with standard margins; 31.2 cm3 vs 15 cm3 for PTV with reduced margins; p = 0.031). With reduced margins the rectum was significantly better spared with an adaptive boost rather than with an up-front boost: V60Gy and V65Gy were 41.2% and 24.8% compared with 59% and 29.9%, respectively (p = 0.031). Median GTV intra-fractional motion was 2 mm (range 0-8 mm). CONCLUSIONS: The data suggest that the adaptive boost strategy exploiting tumor-shrinkage and reduced margin might result in better sparing of rectum and anal canal. Individual margin assessment, motion management and real-time adaptive radiotherapy appear attractive applications of the 1.5 T MR-Linac for further testing of individualized and safe dose escalation in patients with rectal cancer.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Bonomo P, Lo Russo M, Nachbar M, et al. 1.5 T MR-linac planning study to compare two different strategies of rectal boost irradiation. Clin Transl Radiat Oncol. 2020. PMID: 33336086. doi:10.1016/j.ctro.2020.11.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。